An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma
Clinical trial NCT03439761 · UNKNOWN
Trial details
- NCT number
- NCT03439761
- Sponsor
- SciClone Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-07
- Primary completion
- 2020-05-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.